BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
74 results:

  • 1. Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and abcg2 pathway.
    Luo Y; Lu X; Ma W; Xiao Y; Wei C; Yuan X; Wu Y; Wang Y; Xiong Y; Yu X; Wu X; He S; Liu Y; Wang J; Wu Q; Zhou H; Jiang Z
    J Cell Mol Med; 2023 Nov; 27(22):3591-3600. PubMed ID: 37621132
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells.
    Reis JSD; Santos MARDC; da Costa KM; Freire-de-Lima CG; Morrot A; Previato JO; Previato LM; da Fonseca LM; Freire-de-Lima L
    Matrix Biol; 2023 Apr; 118():47-68. PubMed ID: 36882122
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytotoxicity of the methanol extracts and compounds of Brucea antidysenterica (Simaroubaceae) towards multifactorial drug-resistant human cancer cell lines.
    Youmbi LM; Makong YSD; Mbaveng AT; Tankeo SB; Fotso GW; Ndjakou BL; Wansi JD; Beng VP; Sewald N; Ngadjui BT; Efferth T; Kuete V
    BMC Complement Med Ther; 2023 Feb; 23(1):48. PubMed ID: 36793009
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253.
    Yu D; Chang Z; Liu X; Chen P; Zhang H; Qin Y
    Cell Cycle; 2023; 22(6):705-717. PubMed ID: 36416404
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Improvement of cytotoxicity of mitoxantrone and daunorubicin by candidone, tephrosin, and bavachinin.
    Darzi S; Mirzaei SA; Elahian F; Peymani A; Rahmani B; Pishkhan Dibazar S; Shirian S; Shakeri Chaleshtori L; Aali E
    Mol Biol Rep; 2021 Nov; 48(11):7105-7111. PubMed ID: 34564803
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant gastric cancer SGC7901/DDP Cells.
    Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
    Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Investigating Intestinal Transporter Involvement in Rivaroxaban Disposition through Examination of Changes in Absorption.
    Kou W; Sodhi JK; Wu X; Benet LZ
    Pharm Res; 2021 May; 38(5):795-801. PubMed ID: 33847849
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Jianpi Yangwei decoction promotes apoptosis and suppresses proliferation of 5-fluorouracil resistant gastric cancer cells in vitro and in vivo.
    Tang H; Huang W; Yang Q; Lin Y; Chen Y; Shu P
    BMC Complement Med Ther; 2020 Nov; 20(1):337. PubMed ID: 33167958
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer-Containing Antibody-Drug Conjugates.
    Corbett S; Huang S; Zammarchi F; Howard PW; van Berkel PH; Hartley JA
    Mol Cancer Ther; 2020 Sep; 19(9):1856-1865. PubMed ID: 32669316
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancer.
    Ohmura H; Ito M; Uchino K; Okada C; Tanishima S; Yamada Y; Momosaki S; Komoda M; Kuwayama M; Yamaguchi K; Okumura Y; Nakano M; Tsuchihashi K; Isobe T; Ariyama H; Kusaba H; Oda Y; Akashi K; Baba E
    FEBS Open Bio; 2020 Jan; 10(1):147-157. PubMed ID: 31736281
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MicroRNA-328 acts as an anti-oncogene by targeting abcg2 in gastric carcinoma.
    Yan BL; Li XL; An JY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6148-6159. PubMed ID: 31364115
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ribophorin II potentiates P-glycoprotein- and abcg2-mediated multidrug resistance via activating ERK pathway in gastric cancer.
    Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
    Int J Biol Macromol; 2019 May; 128():574-582. PubMed ID: 30710584
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. β-Casein micelles for oral delivery of SN-38 and elacridar to overcome bcrp-mediated multidrug resistance in gastric cancer.
    Bar-Zeev M; Kelmansky D; Assaraf YG; Livney YD
    Eur J Pharm Biopharm; 2018 Dec; 133():240-249. PubMed ID: 30367935
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells.
    Zhuang X; Li X; Zhang J; Hu Y; Hu B; Shi Y; Sun Y; Hong G
    Oncol Rep; 2018 Oct; 40(4):2334-2342. PubMed ID: 30106453
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Upregulation of Breast cancer Resistance Protein Expression was Decreased in Plasma Membrane of Colon cancer with Metastasis of Lymphatic Node.
    Wu A; Zhang J; Zeng L; Li F; Dong Z; Feng Y; Jia X; Jin JO; Zhang L
    Clin Lab; 2018 Mar; 64(3):311-319. PubMed ID: 29739115
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. DIFFERENT CONCENTRATIONS OF SIJUNZI DECOCTION INHIBIT PROLIFERATION AND INDUCE APOPTOSIS OF HUMAN gastric cancer SGC-7901 SIDE POPULATION.
    Qian J; Li J; Jia J; Jin X; Yu D; Guo C; Xie B; Qian L
    Afr J Tradit Complement Altern Med; 2016; 13(4):145-156. PubMed ID: 28852730
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The role of GLI2-abcg2 signaling axis for 5Fu resistance in gastric cancer.
    Yu B; Gu D; Zhang X; Liu B; Xie J
    J Genet Genomics; 2017 Aug; 44(8):375-383. PubMed ID: 28847472
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
    Takegawa N; Nonagase Y; Yonesaka K; Sakai K; Maenishi O; Ogitani Y; Tamura T; Nishio K; Nakagawa K; Tsurutani J
    Int J Cancer; 2017 Oct; 141(8):1682-1689. PubMed ID: 28677116
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
    Yu B; Gu D; Zhang X; Li J; Liu B; Xie J
    Oncotarget; 2017 Apr; 8(16):27412-27427. PubMed ID: 28404967
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Upregulated miR-132 in Lgr5
    Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
    Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.